<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392986</url>
  </required_header>
  <id_info>
    <org_study_id>2018AN0153</org_study_id>
    <nct_id>NCT04392986</nct_id>
  </id_info>
  <brief_title>Effect of Short-term Sunlight Exposure on Blood Pressure and Pulse Rate in Vitamin D3 Insufficient, Prehypertensive Patients</brief_title>
  <official_title>Effect of Short-term Sunlight Exposure on Blood Pressure and Pulse Rate in Vitamin D3 Insufficient, Prehypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Anam Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A three-period parallel (baseline, treatment, and post-treatment) design clinical research
      was conducted. All participants visited a clinical trial center of Korea University Anam
      Hospital for baseline measurement of clinical variables including ABPM and hematologic
      biomarkers (ACTH, aldosterone, norepinephrine, cortisol, and 25-hydroxyvitamin D3). After the
      baseline assessment, participants visited 'Cholipo beach' (Taean, Republic of Korea) for 3
      nights and 4 days for the intervention (sunlight exposure program). After a week of wash-out
      period, post-treatment measurement was processed at Korea University Anam Hospital.
      Participants were prohibited from vigorous physical activity, alcohol drinking, and smoking
      during the study period. A normal-sodium diet (2800 mg/day)[14], caffeine and smoking
      restriction was suggested during the whole study period. To control the effect of circadian
      rhythm on endocrine blood tests and ABPM, we fixed sampling and monitoring start time at
      10:00 am. All participants received the same measurements as they did in the baseline
      measurement during treatment and post-treatment periods.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">June 21, 2019</completion_date>
  <primary_completion_date type="Actual">June 14, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group parallel study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>24 hours</time_frame>
    <description>24 hour ambulatory blood pressure monitoring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pulse rate</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>3 weeks</time_frame>
    <description>Weight in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>3 weeks</time_frame>
    <description>Height in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>3 weeks</time_frame>
    <description>Age in years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>25-hydroxyvitamin D3</measure>
    <time_frame>3 weeks</time_frame>
    <description>ng/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone</measure>
    <time_frame>3 weeks</time_frame>
    <description>ng/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Norepinephrine</measure>
    <time_frame>3 weeks</time_frame>
    <description>pg/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACTH</measure>
    <time_frame>3 weeks</time_frame>
    <description>pg/mL</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Sunlight Exposure</condition>
  <arm_group>
    <arm_group_label>Baseline</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Baseline measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sunlight intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sunlight exposure</intervention_name>
    <description>The weather was sunny and found suitable for outside activity and sunlight exposure program, with a mean temperature of 27.0-28.5 Â°C, the humidity of 64-80%, and global solar exposure of 1.28 to 2.99 MJ/m2 during treatment.[15] Participants were asked to lie on the beach for 45 minutes per day between 2 to 3 pm to avoid extreme skin irritation and sunburn from direct sunlight exposure.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  prehypertensive patients

          -  vitamin D insufficiency

          -  age 20-45

        Exclusion Criteria:

          -  medical comorbidity other than prehypertension

          -  participant using medication

          -  Subjects with a history of cardiovascular, renal, hepatic, gastrointestinal,
             hematologic, psychological, or gastrointestinal abnormalities, taking any kind of
             medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2020</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Anam Hospital</investigator_affiliation>
    <investigator_full_name>Ji-Young Park</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

